The content is available as a PDF (335.7 KB).
References
- 1. Dienhart, F. & Holmes A. W.. 1965. Epidemiology and etiology of viral hepatitis In Progress in Liver Diseases, Popper H. & Schaffner F., Eds. Vol. 2: 373 Grune, New York , N.Y. [Google Scholar]
- 2. Sidwell, R. W. , Huffman J. H., Khare C. P., Allen L. B., Witkowski J. T. & Robins R. K.. 1972. Broad‐spectrum antiviral activity of Virazole: 1‐β‐D‐ribofuranosyl‐1,2,4‐triazole‐3‐carboxamide. Science 177: 705–706. [DOI] [PubMed] [Google Scholar]
- 3. Witkowski, J. T. , Robins R. K., Sidwell R. W. & Simon L. N.. 1972. Design, synthesis and broad‐spectrum antiviral activity of 1‐β‐D‐ribofuranosyl‐1,2,4‐triazole‐3‐carboxamide and related and related nucleosides. J. Med.Chem. 15: 1150–1154. [DOI] [PubMed] [Google Scholar]
- 4. Huffman, J. H. , Sidwell R. W., Khare G. P., Witkowski J. T., Allen L. B. & Robins R. K.. 1973. In vitro effect of 1‐β‐D‐ribofuranosyl‐1,2,4‐triazole‐3‐carboxamide (Virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob. Ag. Chemother. 3: 235–241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Simon, L. N. , Sidwell R. W., Khare G. P., Streeter D. G., Miller J. P., Witkowski J. T., Huffman J. H. & Robins R. K.. 1973. Molecular basis of antiviral chemotherapy: Virazole, a new broad‐spectrum antiviral agent In Virus Research, 2nd ICN‐UCFA Symposium on Molecular Biology, Fox C. F. and Robinson W. S., Eds.: 415–436. Academic Press, New York , N.Y. [Google Scholar]
- 6. Sidwell, R. W. , Witkowski J. T. & Robins R. K.. 1974. Antiviral activity of Virazole: Review and structure‐activity relationships. 1974. Prog. Chemother., Proc. 8th Int. Congr. Chemother., Athens, Greece. 2: 889–903. [Google Scholar]
- 7. Miller, J. P. , Streeter D. G., Robins R. K. & Simon L. N.. 1976. The relationship between the metabolism of ribavirin and its proposed mechanism of action. Ann. N.Y. Acad. Sci. This volume. [DOI] [PubMed]
- 8. Braunsteiner, H. & Friend C.. 1954. Viral hepatitis associated with transplantable mouse leukemia. I. Acute hepatic manifestations following treatment with urethane or methylformamide. J. Exp. Med. 100: 665–677. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Doll, E. R. , Bryans J. T., Mccollum W. H. & Crowe E. W.. 1956. Propagation of equine abortion virus in Syrian hamsters. Cornell Vet. 46: 68–82. [PubMed] [Google Scholar]
- 10. Randall, C. C. & Bracken E. C.. 1957. Studies on hepatitis in hamsters infected with equine abortion virus. I. Sequential development of inclusion and growth cycle. Amer. J. Pathol. 33: 709–727. [PMC free article] [PubMed] [Google Scholar]
- 11. Friend, C. , Wroblewski F. & La Due J. S.. 1955. Glutamic‐oxalacetic transaminase activity of serum in mice with viral hepatitis. J. Exp. Med. 102: 699–704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Sigma Technical Bulletin No. 505. Sigma Chemical Co., St. Louis, Mo.
- 13. Nosslin, B. 1960. The direct direct diazo reaction of bile pigments in serum. Experimental and clinical studies. Scand. J. Clin. and Lab. Invest. 12(Suppl. 49):1–176. [Google Scholar]
- 14. Cavallini, G. , Massarani E. & Nardi D.. 1964. Antiviral compounds. IX. Steroid derivatives. J. Med. Chem. 7: 673–675. [DOI] [PubMed] [Google Scholar]
- 15. Anderson, E. L. , Casey J. E., Jr., E. E. Force. Jensen E. M., Matz R. S. & Rivard D. E.. 1966. Antiviral agents. II. Substituted morpholinium quaternary salts. J. Med. Chem. 9: 211–213. [DOI] [PubMed] [Google Scholar]
- 16. Judah, J. D. , Bjotvedt G. & Vainio T.. 1960. Protection against liver injury due to murine hepatitis virus. Nature 187: 507–508. [DOI] [PubMed] [Google Scholar]
- 17. Stone, R. L. , De Long D. C., Hull R. N. & Johnson I. S.. 1965. In vivo and in vitro hibition of hepatitis viruses by streptothricin. Ann. N.Y. Acad. Sci. 130: 355–364. [DOI] [PubMed] [Google Scholar]
- 18. Lieberman, M. , Pascale A., Schafer T. W. & Came P. E.. 1972. Effect of antiviral agents in equine abortion virus‐infected hamsters. Antimicrob. Ag. Chemother. 1: 143–147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Allen, L. B. , Huffman J. H., Revankar G. R., Tolman R. L., Simon L. N., Robins R. K. & Sidwell R. W.. 1975. Efficacy of 9‐β‐D‐ribofuranosylhypoxanthine‐5′‐monophosphate in therapy of equine abortion virus‐induced hepatitis in hamsters. Antimicrob. Ag. Chemother. 8: 474–478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Streeter, D. G. , Witkowski J. T., Khare G. P., Sidwell R. W., Bauer R. J., Robins R. K. & Simon L. N.. 1973. Mechanism of action of 1‐β‐D‐ribofuranosyl‐1,2,4‐triazole‐3‐carboxamide (Virazole), a new broad‐spectrum antiviral agent. Proc. Nat. Acad. Sci. U.S.A. 70: 1174–1178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Oxford, J. S. 1975. Inhibition of the replication of influenza A and B viruses by a nucleoside analogue (ribavirin). J. Gen. Virol. 28: 409–414. [DOI] [PubMed] [Google Scholar]
- 22. Zuniga, C. B. A. Almeida , Iervolino A. C. L., Castro I. O., & Galvao P. A. A.. 1974. Acao do l‐beta‐D‐ribofuranosyl‐1,2,4‐triazol‐3‐carboxamida no tratamento das hepatites virais agudas. Rev. Assoc. Med. Brasil 20: 386–390. [PubMed] [Google Scholar]
- 23. Vilela, M. P. , Siqueira W. A., Domingues S. H. S., Rodrigues L. D. & Rodrigues F. S.. 1974. Comportamento do antigeno Australia nos casos de hepatite por virus tratados com o l‐beta‐D‐ribofuranosyl‐1,2,4‐triazol‐3‐carboxamide. Rev. Bras. Clin. Terap. 3: 27–28. [Google Scholar]